Wilhelmina (Willemijn) T.
- Country
- The Netherlands
- Department
- Pulmonology
Research Overview
Data & Insights
Has run more than one trial at 1 of 118 partner sites.
Specializations
Non-Small Cell Lung Cancer Treatment
The investigator specializes in developing innovative therapeutic approaches for advanced non-small cell lung cancer (NSCLC), with particular emphasis on immunotherapy combinations and targeted treatments.
- Checkpoint Inhibitor Therapies
- KRAS G12C Mutation Targeting
- Combination Immunotherapy Strategies
Research activities focus on evaluating novel drug combinations and treatment sequences for patients with advanced NSCLC.
Small Cell Lung Cancer Research
Expertise in investigating treatment modalities for limited disease small-cell lung cancer (LD SCLC), particularly exploring the integration of immunotherapy with conventional treatments.
- Chemoradiotherapy Enhancement
- Immunotherapy Integration
- Treatment Sequencing
The investigator studies innovative approaches to improve survival outcomes in SCLC patients.
Advanced Therapeutic Approaches
Focused on developing multi-modal treatment strategies for lung cancer, including the investigation of novel drug combinations and immunotherapy applications.
- Cancer Vaccine Development
- Brain Metastases Treatment
- Maintenance Therapy Optimization
Research encompasses both early-stage and metastatic disease management approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.